 |
5 Diseases |  |
1 Trial |
|
1 Trial |  |
5 News |  |
- ||| LAPS Insulin 115 (HM12470) / Sanofi
Trial completion, Trial primary completion date: A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470 (clinicaltrials.gov) - Nov 8, 2017
P1, N=100, Completed, Sponsor: Hanmi Pharmaceutical Company Limited
Recruiting --> Completed | Trial primary completion date: Sep 2016 --> May 2017
- ||| LAPS Insulin 115 (HM12470) / Sanofi
New P1 trial: Molar Potency Study of HM12470 in Healthy Subjects (clinicaltrials.gov) - Nov 6, 2017
P1, N=56, Completed, Sponsor: Hanmi Pharmaceutical Company Limited
- ||| LAPS Insulin 115 (HM12470) / Sanofi
New P1 trial: Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus (clinicaltrials.gov) - Nov 6, 2017
P1, N=60, Active, not recruiting, Sponsor: Hanmi Pharmaceutical Company Limited
- ||| LAPS Insulin 115 (HM12470) / Sanofi
Enrollment open, Trial primary completion date: A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470 (clinicaltrials.gov) - Apr 8, 2016
P1, N=100, Recruiting, Sponsor: Hanmi Pharmaceutical Company Limited
Recruiting --> Completed | Trial primary completion date: Sep 2016 --> May 2017 Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2015 --> Sep 2016
- ||| LAPS Insulin 115 (HM12470) / Sanofi
New P1 trial: A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470 (clinicaltrials.gov) - Nov 28, 2014
P1, N=100, Not yet recruiting, Sponsor: Hanmi Pharmaceutical Company Limited